Resensitizing Paclitaxel-Resistant Ovarian Cancer via Targeting Lipid Metabolism Key Enzymes CPT1A, SCD and FASN

Epithelial ovarian cancer (EOC) is a lethal gynecological cancer, of which paclitaxel resistance is the major factor limiting treatment outcomes, and identification of paclitaxel resistance-related genes is arduous. We obtained transcriptomic data from seven paclitaxel-resistant ovarian cancer cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Qinsiyu, Liu, Zhan’ao, Wang, Tengyu, Zhao, Pengfei, Liu, Mingrui, Wang, Yifang, Zhao, Weitong, Yuan, Ying, Li, Shuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671839/
https://www.ncbi.nlm.nih.gov/pubmed/38003694
http://dx.doi.org/10.3390/ijms242216503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671839/
https://www.ncbi.nlm.nih.gov/pubmed/38003694
http://dx.doi.org/10.3390/ijms242216503

Ejemplares similares